[ESPR] YoY Quarter Result on 30-Sep-2013 [#Q3]

Stock
[ESPR] Esperion Therapeutics, Inc.
Announcement Date
06-Nov-2013
Financial Year
2013
Quarter
30-Sep-2013 [#Q3]
Profit Trend
QoQ- 24.32%
YoY- -56.31%
Quarter Report
ESPR's Result
ESPR's Financial Summary
View:
Show?
Quarter Result
30/09/16 30/09/15 30/09/14 30/09/13 30/09/12 30/09/03 30/09/02 CAGR
Revenue 0 0 0 0 0 0 0 -
PBT -17,402 -12,801 -9,806 -5,238 -3,351 -6,563 -6,980 6.73%
Tax 488 378 164 168 362 578 177 7.50%
NP -17,402 -12,801 -9,806 -5,238 -3,351 -6,563 -6,980 6.73%
Tax Rate - - - - - - - -
Total Cost 17,402 12,801 9,806 5,238 3,351 6,563 6,980 6.73%
Ratio Analysis
30/09/16 30/09/15 30/09/14 30/09/13 30/09/12 30/09/03 30/09/02 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
30/09/16 30/09/15 30/09/14 30/09/13 30/09/12 30/09/03 30/09/02 CAGR
EPS -0.77 -0.57 -0.64 -0.34 -0.35 -1.42 -1.67 -5.37%
EPS Diluted -0.77 -0.57 -0.64 -0.34 -0.35 -1.42 -1.67 -5.37%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.